Equities

TOT BIOPHARM International Co Ltd

TOT BIOPHARM International Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)1.97
  • Today's Change0.00 / 0.00%
  • Shares traded34.00k
  • 1 Year change-6.19%
  • Beta0.0905
Data delayed at least 15 minutes, as of Jul 03 2024 07:56 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

TOT BIOPHARM International Company Limited is a company mainly engaged in the development and commercialization of oncology drugs and therapies. The Company has a portfolio of oncology drug candidates, which include monoclonal antibodies (mAbs), antibody drug conjugates (ADCs), oncolytic virus products and specialty oncology drugs such as liposome drugs.

  • Revenue in HKD (TTM)839.03m
  • Net income in HKD-40.58m
  • Incorporated2009
  • Employees551.00
  • Location
    TOT BIOPHARM International Co Ltd120 Changyang StreetSuzhou Industrial ParkSuzhou 215024ChinaCHN
  • Phone+86 51 262965186
  • Fax+86 51 262965286
  • Websitehttps://www.totbiopharm.cn/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Brii Biosciences Ltd663.16k-187.91m737.15m128.00--0.2198--1,111.56-0.2583-0.25830.00094.600.0002----5,180.96-5.60---5.84-------29,881.69------0.001---98.80--63.90------
JW (Cayman) Therapeutics Co Ltd186.86m-825.46m784.30m398.00--0.4307--4.20-2.01-2.010.45414.390.07041.6865.54469,506.40-31.11-39.77-35.21-44.0050.74---441.74-1,316.813.86-47.820.1592--19.32--9.23---19.87--
Sunho Biologics Inc-100.00bn-100.00bn1.05bn-------------------------------------------------------155.25------
Jacobio Pharmaceuticals Group Co Ltd68.27m-385.99m1.16bn301.00--1.01--17.00-0.4993-0.49930.08831.460.0419--5.21226,818.80-23.66-45.76-26.86-49.305.04---565.36-372.22----0.1636---33.66--3.43--19.18--
TOT Biopharm International Co Ltd839.03m-40.58m1.45bn551.00--1.97277.441.73-0.056-0.0561.160.95510.58081.878.031,522,748.00-2.81-20.01-3.72-25.2173.5374.74-4.84-68.531.48-4.600.3348--76.5481.8824.36--21.04--
CStone Pharmaceuticals498.55m-394.71m1.46bn230.00--2.98--2.94-0.3129-0.31290.39470.38240.28112.443.722,167,590.00-22.25-54.76-48.85-81.6865.60---79.17-301.621.44--0.4431---3.64--59.32--52.42--
Frontage Holdings Corp2.03bn84.43m1.49bn1.76k17.870.55494.110.7320.04090.04090.98081.320.46360.635.321,154,072.001.914.462.335.2830.1734.004.139.921.394.090.2960.003.7925.61-58.00-0.782640.43--
Wuhan YZY Biopharma Co Ltd0.00-206.04m1.57bn123.00--11.42-----1.11-1.110.000.7078------0.00----------------1.41-100.120.4138-------1.50------
Hua Medicine82.34m-227.04m1.59bn177.00--13.62--19.36-0.2323-0.23230.08430.11090.05381.6913.03465,208.00-14.84-25.61-17.56-28.8148.78---275.73-1,654.706.06--0.6238--335.31---3.80--14.07--
Mabpharm Ltd93.68m-225.02m1.63bn347.00--7.39--17.39-0.0546-0.05460.02270.05340.08930.11766.02269,977.60-21.44-21.42-28.92-27.4986.32---240.19-486.400.7596-19.030.5591--55.87--0.694---26.85--
Immunotech Biopharm Ltd0.00-359.87m1.63bn211.00--8.74-----0.6993-0.69930.000.36260.00----0.00-38.88-37.42-50.88-45.48--------1.03-2.510.4327-------5.25---8.46--
Laekna Inc0.00-396.41m1.90bn89.00--2.20-----3.28-3.280.002.22------0.00-------------------5.280.0655------52.81------
Data as of Jul 03 2024. Currency figures normalised to TOT BIOPHARM International Co Ltd's reporting currency: Hong Kong Dollar HKD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.